Related Experiment Video
Updated: Mar 29, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Response shift and disease activity in inflammatory bowel disease
Lisa M Lix1, Eric K H Chan2,3, Richard Sawatzky3,4
1Department of Community Health Sciences, College of Medicine, University of Manitoba, Winnipeg, MB, R3E 0W3, Canada. Lisa.Lix@umanitoba.ca.
Response shift (RS) can affect health-related quality of life (HRQoL) in chronic conditions. This study found RS in inflammatory bowel disease (IBD) patients, regardless of consistent symptom activity, highlighting its impact on HRQoL assessments.
Area of Science:
- Health Services Research
- Psychometrics
- Gastroenterology
Background:
- Response shift (RS) can confound longitudinal health-related quality of life (HRQoL) assessments.
- Chronic conditions, such as inflammatory bowel disease (IBD), involve fluctuating disease activity, potentially influencing RS.
- Understanding RS in IBD is crucial for accurate HRQoL measurement.
Purpose of the Study:
- To investigate the presence and types of response shift (RS) in individuals with inflammatory bowel disease (IBD).
- To examine whether varying disease activity (consistent active, consistent inactive, inconsistent) influences RS over a 6-month period.
- To assess RS using the SF-36 quality of life measure.
Main Methods:
- Utilized data from the Manitoba IBD Cohort Study (N=388).
- Employed multi-group confirmatory factor analysis (MG-CFA) and a structural equation modeling-based RS detection method.
- Analyzed RS (reconceptualization, reprioritization, recalibration) across groups with different disease activity patterns.
Main Results:
- Weak invariance model best fit baseline SF-36 data.
- Reconceptualization and recalibration RS detected in the consistent active IBD group (small effect sizes).
- Recalibration RS observed in consistent inactive and inconsistent disease activity groups (small to moderate effect sizes). No reprioritization RS found.
Conclusions:
- Individuals with chronic diseases like IBD may experience RS even without consistent active symptoms.
- The type and magnitude of RS can vary among patients with fluctuating disease activity.
- RS can impact the interpretation of HRQoL changes in longitudinal studies of chronic conditions.
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

